Every 8-K that Odysight.ai Inc. (ODYS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ODYS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ODYS filings page.
Odysight.ai Inc. (ODYS) entered into an Underwriting Agreement with Roth Capital Partners, LLC for a firm commitment underwritten public offering of 3,437,500 shares of common stock at a public offering price of $3.20 per share. This implies expected gross proceeds of $11 million before underwriting discounts, commissions, and other offering expenses. Odysight.ai intends to use the net proceeds for research and development, sales and marketing including scaling commercial operations, and for working capital and other general corporate purposes.
The underwriters have a 30-day option to purchase up to an additional 515,625 shares, representing 15% of the Firm Shares, at the same public offering price less underwriting discounts and commissions. The Representative will receive 6.5% of the gross proceeds as underwriting discounts and commissions, and up to $75,000 as expense reimbursement. Odysight.ai, its directors, and executive officers agreed to a 45-day lock-up, restricting sales or transfers of common stock without the Representative’s consent. The shares are being issued under an effective Form S-3 shelf registration and a final prospectus supplement. Separately, Odysight.ai terminated its prior at-the-market Sales Agreement and related prospectus for up to $20,000,000 of common stock, and disclosed that no sales were made under that program.
Odysight.ai Inc. (ODYS) announced the pricing of a firm commitment underwritten public offering of 3,437,500 shares of its common stock at $3.20 per share, for expected gross proceeds of $11 million before underwriting discounts, commissions and expenses. All shares are being sold by the company.
The company granted Roth Capital Partners a 30-day option to purchase up to 515,625 additional shares, equal to 15% of the base offering. Net proceeds are intended for research and development, sales and marketing to scale commercial operations, and for working capital and other general corporate purposes. The offering is expected to close on or about August 21, 2026, subject to customary closing conditions, and is being conducted under an effective shelf registration statement on Form S-3.
Odysight.ai Inc. reported first-half 2026 revenues of $0.5 million, down from $2.4 million a year earlier, reflecting prior-year revenue from a Fortune 500 medical customer and the timing of order execution. Gross profit was $0.2 million, and operating expenses rose slightly to $10.0 million, driven by expanded global sales and marketing and FX effects. Net loss widened to $9.5 million from $8.3 million.
Backlog was $14.1 million as of June 30, 2026 and approximately $16.45 million as of the release date, and the company ended the period with about $17.6 million in cash and no debt. Management highlights new purchase orders from Boeing, Elbit Systems (on behalf of the Israeli Ministry of Defense), and Honeywell Aerospace, as well as U.S. test flights on a UH-60 Black Hawk and a CRADA with the U.S. Navy’s NAWCAD. The company states that revenues are expected to be weighted toward the second half of 2026 as existing orders convert into deliveries.
Odysight.ai Inc. entered into a new Sales Agreement with Roth Capital Partners that allows it to sell up to $20,000,000 of common stock in at-the-market offerings. Shares may be sold from time to time at prevailing market prices or through privately negotiated transactions.
Roth Capital will act as sales agent and/or principal and can earn a commission of up to 3.0% of the gross proceeds on shares sold. Odysight.ai will reimburse up to $75,000 of initial expenses and up to $7,500 per quarter for ongoing expenses. Any shares sold will be issued under the company’s effective Form S-3 shelf registration.
Odysight.ai Inc. reported that its board, following a recommendation from the Compensation Committee, granted Chief Operating Officer Ronen Tanami an option to purchase 40,000 shares of common stock under the 2024 Stock Incentive Plan at an exercise price of $5.09 per share.
One-third of the option vests on the first anniversary of the grant date, with the remaining shares vesting over the following two years in eight equal quarterly installments, as long as Tanami remains a service provider. The option includes accelerated vesting if there is a change of control of the company.
Odysight.ai Inc. reported weak results for the three months ended March 31, 2026, as revenue dropped to $82 thousand from $2.1 million a year earlier. Management attributes the decline mainly to prior-period contract derecognition and delayed purchase order execution amid geopolitical disruptions.
Gross profit was $21 thousand with a gross margin of about 26%, similar to last year, while operating expenses rose to roughly $5.4 million, reflecting expanded global sales and marketing. Net loss widened to approximately $5.2 million from $4.3 million. The company ended the quarter with about $21.8 million in cash and a backlog of $14 million, and it remains confident in its 2026 business targets.
Odysight.ai Inc. furnished an updated investor presentation on its website on April 10, 2026, and attached it as Exhibit 99.1 to this report. The presentation may be used in discussions with investors, analysts, and other third parties and is provided under Regulation FD as “furnished,” not “filed,” under the Exchange Act.
Odysight.ai Inc. is adding a dual listing for its common stock on the Tel Aviv Stock Exchange. The shares have been approved for listing, with trading on TASE expected to begin on April 9, 2026 under the ticker ODYS (also “אודס” in Hebrew).
The stock will continue to trade on the Nasdaq Capital Market while also being traded on TASE in Israeli Shekels. The company states that the dual listing is intended to broaden its investor base, enhance trading liquidity, improve accessibility for Israeli and international investors, and strengthen its presence in the Israeli capital market as part of its long-term global growth strategy.
Odysight.ai Inc. reported that investors exercised previously issued warrants, leading to the issuance of new shares without the company receiving cash. These warrants came from a March 2023 private placement of 3,294,117 units, each containing one share of common stock and one warrant with a $5.50 exercise price.
On March 25, 2026, the investors exercised all of these warrants on a cashless basis, and the company issued 407,497 shares of common stock as a result. The transaction was conducted as an unregistered sale of equity securities and relates back to terms originally disclosed in an earlier Form 8-K.
Odysight.ai reported full year 2025 revenue of $3.0 million, down from about $4.0 million in 2024, as it wound down a legacy Fortune 500 medical contract and shifted toward aerospace, defense, and industrial predictive maintenance and condition-based monitoring.
Core vision-based PdM/CBM platform revenue grew about 23% year-over-year to $1.2 million, and backlog reached roughly $13.8 million as of December 31, 2025, supporting future revenue. Gross margin held near 29%, but operating expenses increased to $19.0 million from $13.7 million as the company invested in product development, sales and marketing, global expansion, and Nasdaq uplisting costs.
Net loss widened to $17.0 million from $11.8 million. Odysight.ai ended 2025 with approximately $26 million in cash, up from about $18.5 million, and no debt, after a February 2025 underwritten public offering that raised about $23.7 million in gross proceeds. Management is also exploring a potential dual listing on the Tel Aviv Stock Exchange.
Odysight.ai Inc. filed an 8‑K stating it furnished a press release with financial results for the nine months ended September 30, 2025 and a business update. The release is attached as Exhibit 99.1 and incorporated by reference.
The company noted the information is furnished under Item 2.02 and is not deemed filed under the Exchange Act. Odysight.ai’s common stock trades on the Nasdaq Capital Market under the symbol ODYS.
Odysight.ai Inc. furnished an updated investor presentation on its website, with a version dated August 2025 attached as Exhibit 99.1. This presentation is meant to provide investors with current company information in a more visual and accessible format, but it is being treated as "furnished" rather than "filed" under securities laws, which limits certain legal liabilities. The company’s common stock continues to trade on the Nasdaq Capital Market under the symbol ODYS.
Odysight.ai Inc. furnished an 8-K to report that it issued a press release with its financial results for the first half of 2025 and a business update. The press release is included as Exhibit 99.1 and is incorporated by reference. The information in this report, including the exhibit, is being furnished rather than filed, which limits its exposure to certain Exchange Act liabilities.